IBD Disease Course of Infliximab-naïve IBD Patients Treated With Subcutaneous Infliximab CT-P13 Remsima®
Clinical trial NCT05722353 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05722353
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-13
- Primary completion
- 2025-11-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.